Predictors and Trends in First-Trimester Hemoglobin A1c Screening in New York City, 2009 to 2017.

Autor:	Vieira L; Department of Obstetrics and Gynecology, Stamford Health System, Stamford, Connecticut., McCarthy K; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York City.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City., Liu SH; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City., Huynh M; Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City., Kennedy J; Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City., Chan HT; Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City., Mayer VL; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City.; Department of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City., Tabaei B; Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City., Howell F; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City., Wye GV; Department of Health & Mental Hygiene, Bureau of Vital Statistics, New York City., Howell EA; Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Janevic T; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York City.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City.
Jazyk:	angličtina
Zdroj:	American journal of perinatology [Am J Perinatol] 2024 May; Vol. 41 (S 01), pp. e2752-e2758. Date of Electronic Publication: 2023 Aug 21.
DOI:	10.1055/a-2157-2944
Abstrakt:	Glycated hemoglobin is an adjunct tool in early pregnancy to assess glycemic control. We examined trends and maternal predictors for those who had A1c screening in early pregnancy using hospital discharge and vital registry data between 2009 and 2017 linked with the New York City A1C Registry ( N  = 798,312). First-trimester A1c screening increased from 2.3% in 2009 to 7.7% in 2017. The likelihood of screening became less targeted to high-risk patients over time, with a decrease in mean A1c values from 5.8% (95% confidence interval [CI]: 5.8, 5.9) to 5.3 (95% CI: 5.3, 5.4). The prevalence of gestational diabetes mellitus increased while testing became less discriminate for those with high-risk factors, including pregestational type 2 diabetes, chronic hypertension, obesity, age over 40 years, as well as Asian or Black non-Hispanic race/ethnicity. KEY POINTS: · First-trimester A1c screening increased from 2.3% in 2009 to 7.7% in 2017 in New York City.. · The likelihood of screening became less targeted to high-risk patients over time.. · The prevalence of gestational diabetes mellitus increased, while testing became less discriminate.. Competing Interests: None declared. (Thieme. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu